Click here to see a list of our past events.
Do you have a project in need of funding? Are you interested in learning about engaging with industry partners?
James Bellush, Manager of Scientific Scouting, will be hosting weekly virtual office hours, every Friday from 11 a.m. to 1 p.m. to help Weill Cornell investigators support their ongoing translational research projects through industry sponsored research collaborations and grants.
Please use the link here to schedule your private meeting with James. Questions? Email james.bellush@cornell.edu.
This unique Weill Cornell Graduate School Alumni Advisory Council series celebrates alumni who exemplify bold leadership—those who take risks, transform setbacks into opportunities, and push the boundaries of their fields. Designed as an engaging Q&A conversation, "The Biggest Learner" will offer firsthand insight into how exceptional leaders think, persevere, and innovate.
The June 17th session features Dr. Brian Wong (M.D. ’01, Ph.D.). AAC co-chairs Dr. Sara Glickstein Bar-Zeev (Ph.D. ’00) and Dr. Rana Sawaya (Ph.D. ’04) will interview Brian. Find out how his company, RAPT Therapeutics, was acquired by GSK.
Most life science companies don't fail because the science was wrong. They fail because no one validated the problem, the customer, or the market before spending years and millions building toward them. They fail because no one left the lab — or the pitch deck — long enough to find out whether the problem they were solving was real, or whether the customer they imagined actually existed.
This webinar, moderated by Dr. Donna Rounds, associate director of Business Development and Licensing, CTL at Weill Cornell, brings together three practitioners who have confronted this challenge from radically different vantage points:
- Audrey Beckman, partner and chief innovation officer at Boomerang Ventures, who evaluates and co-builds health tech companies
- Dave Saunders, product development advisor at AiM Medical Robotics, where an MRI-guided neurosurgery robot has just completed first-in-human trials
- Dr. Amir Goldan, associate professor and serial inventor of Prism-PET and NeuroTwain at Weill Cornell Medicine, who is navigating the leap from lab to market
Join us to find out more.
PORTENT translates breakthrough point-of-care diagnostics into rapid, affordable tests that reduce the burden of chronic disease, curb infectious threats, and strengthen prevention efforts across the United States.
The PORTENT 2026 Technology Showcase will bring together current PORTENT performer teams along with a select group of companies from the New York City/Cornell ecosystem developing promising point-of-care diagnostics, digital health tools, clinical screening technologies, monitoring platforms, and related medical technologies.
Join us to connect with startups, investors, industry partners, clinicians, researchers, students, commercialization experts and others interested in advancing point-of-care health technologies. Register here.
